Quorum Technologies Names XStor Systems Exclusive Pathology Image Storage Partner for Canadian Market

Partnership with Leading Biomedical Equipment Distributor Includes XStorPath™, a Digital Image Storage and Management Solution Developed Specifically for Pathologists

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--XStor Systems, Inc., a provider of next-generation, specialty-specific digital imaging storage and connectivity solutions for radiology, pathology, and oncology, announced today an exclusive partnership with Quorum Technologies, Canada’s leading provider of microscope-based equipment and image processing solutions for scientists, clinicians and laboratories. Through this new partnership, Quorum will be the exclusive distributor of the XStorPath digital image storage and management system for the Canadian pathology market.

“Our patented technology is designed with the realities of today’s image intensive clinical workflow in mind”

“We are pleased Quorum recognizes the value XStor brings to today’s pathology lab, and we’re excited to be a key component of their digital pathology solutions family,” said Thomas Leahy, Executive Vice President of Sales and Marketing for XStor Systems.

XStorPath is a complete solution of onsite enterprise-class storage, pathology-centric management software and 24-hour remote support. Available for licensed purchase or as a pay-as-you-go subscription, XStorPath is designed to make it easy and inexpensive for pathology labs of every size to implement a digital imaging workflow. XStorPath’s vendor-independent platform ensures seamless integration with whole-slide imaging (WSI) scanners from all major equipment vendors.

“For the past 25 years, we’ve made it our mission to thoroughly understand the needs of clinical labs and help them achieve their goals with integrated, robust and flexible imaging systems,” said John Arbuckle, CEO of Quorum Technologies. “Our partnership with XStor Systems will help us to provide pathology labs with a complete digital workflow solution with tools developed specifically for their needs.”

XStor’s distribution partnership with Quorum also includes current and upcoming image storage and connectivity solutions. Using image caching technology patented by XStor, storage management software optimizes image data access and retrieval speed across a distributed care environment without compromising security or scalability.

“Our patented technology is designed with the realities of today’s image intensive clinical workflow in mind,” said Syed Hamdani, President and CEO of XStor Systems. “By developing storage management solutions optimized for multi-location and multi-vendor environments, clinicians and labs can improve the lifecycle of patient care.”

About XStor Systems

XStor Systems, Inc., provides next-generation digital image storage and connectivity solutions to meet radiology, oncology and emerging digital pathology market needs. XStor’s vendor-neutral archiving and connectivity platform enables hospitals, clinics and clinical research labs to intelligently organize and instantly retrieve digital images and relevant patient information. With highly scalable solutions that leverage existing infrastructure, XStor accommodates rapid growth without compromising data security, quality and availability. To learn more, please visit http://www.xstorsystems.com.

About Quorum Technologies

Quorum Technologies Inc. is a private Canadian owned enterprise located in Guelph, Ontario. The company develops and integrates scientific instruments and is the largest independent provider of Microscope based imaging systems in Canada. Quorum is a leader in advanced Live Cell Imaging platforms and holds over half a dozen patents with several others in process. Through its technology transfer relationships with Canadian Universities, Quorum is helping to bring new innovative technologies to market for use in preclinical research, drug development and personalized medicine. http://www.quorumtechnologies.com

Source:
http://feeds.feedburner.com/DigitalPathologyBlog

Related Posts

Comments are closed.